Search

Author/Creator Johnson, Amber

1. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform. Issue 12 (December 2015)

Authors:
Johnson, Amber; Zeng, Jia; Bailey, Ann M.; Holla, Vijaykumar; Litzenburger, Beate; Lara-Guerra, Humberto; Mills, Gordon B.; Mendelsohn, John; Shaw, Kenna R.; Meric-Bernstam, Funda
Journal:
Drug discovery today
Issue:
Volume 20:Issue 12(2015)
Page Start:
1433
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. (4th May 2018)

Authors:
Li, Howard Y.; McSharry, Maria; Walker, Deandra; Johnson, Amber; Kwak, Jeff; Bullock, Bonnie; Neuwelt, Alexander; Poczobutt, Joanna M.; Sippel, Trisha R.; Keith, Robert L.; Weiser-Evans, Mary C. M.; Clambey, Eric; Nemenoff, Raphael A.
Journal:
Oncoimmunology
Issue:
Volume 7:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion. Issue 11 (10th April 2022)

Authors:
Chakravarty, Debyani; Johnson, Amber; Sklar, Jeffrey; Lindeman, Neal I.; Moore, Kathleen; Ganesan, Shridar; Lovly, Christine M.; Perlmutter, Jane; Gray, Stacy W.; Hwang, Jimmy; Lieu, Christopher; André, Fabrice; Azad, Nilofer; Borad, Mitesh; Tafe, Laura; Messersmith, Hans; Robson, Mark; Meric-Ber...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 11(2022)
Page Start:
1231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗